The DEA’s June 29 Hearing Explained: What Full Cannabis Rescheduling Would Mean for Medical Patients
Comments Off on The DEA’s June 29 Hearing Explained: What Full Cannabis Rescheduling Would Mean for Medical Patients
June 14, 2026
A federal DEA hearing beginning June 29, 2026 will determine whether all cannabis -- not just state-licensed medical marijuana -- moves from Schedule I to Schedule III. Here's what already changed on April 28, what the hearing is actually deciding, and…
DEA Places 2-Fluorodeschloroketamine in Schedule I Controlled Substances
Comments Off on DEA Places 2-Fluorodeschloroketamine in Schedule I Controlled Substances
June 9, 2026
The DEA has temporarily placed 2-fluorodeschloroketamine in Schedule I of the Controlled Substances Act, reflecting regulatory action against emerging synthetic ketamine analogs. This DEA Schedule I classification demonstrates the federal approach to…